Compare Johnson & Johnson (JNJ) vs Quanta Services Inc (PWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Quanta Services Inc — how do they compare? Johnson & Johnson trades at $261.43 (market cap $618.09B), while Quanta Services Inc trades at $700.31 (market cap $103.03B). The key difference: Johnson & Johnson is far larger — about 6× Quanta Services Inc's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Quanta Services Inc for 62 Days on average.
| JNJ | PWR | |
|---|---|---|
Market Cap | $618.09B | $103.03B |
Volume | 6,050,983 | 977,892 |
Sector | Health | Industrials |
52-Week High | $278.43 | $785.24 |
52-Week Low | $186.00 | $412.21 |
Typical Hold Time | 129 Days | 62 Days |
Enterprise Value | $646.37B | $109.13B |
Dividend Yield | 2.09% | 0.06% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
PWR trades at $705.94, up 0.69% today, with a bullish technical signal and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue growth is robust, reaching $28.48B in 2025, though valuation multiples like a P/E of 78.41 appear elevated. Positive sentiment is driven by a record $53B backlog and AI infrastructure demand, as highlighted in recent Zacks reports.
Outlook remains positive given earnings momentum and sector tailwinds, but high valuation and execution risks from rapid expansion warrant caution. The consensus price target of $802.08 implies upside, yet investors should monitor margin sustainability and competitive pressures in the construction and electrical services sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Quanta Services Inc
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →
